Evidence map›Paper›PMID 26559323›Full record

ArticleThe Journal of allergy and clinical immunology2016

Fold stability during endolysosomal acidification is a key factor for allergenicity and immunogenicity of the major birch pollen allergen.

Yoan Machado, Regina Freier, Sandra Scheiblhofer, Theresa Thalhamer, Melissa Mayr, Peter Briza, Sarina Grutsch, Linda Ahammer, Julian E Fuchs, Hannes G Wallnoefer and 14 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Mucosal vaccination with enzymatically activeFrontiers in microbiology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 4 institutions in 2 countries.

Yoan MachadoDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Regina FreierDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Sandra ScheiblhoferDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Theresa ThalhamerDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Melissa MayrDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Peter BrizaDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Sarina GrutschCenter of Molecular Biosciences & Institute of Organic Chemistry, University of Innsbruck, Innsbruck, Austria.
Linda AhammerCenter of Molecular Biosciences & Institute of Organic Chemistry, University of Innsbruck, Innsbruck, Austria.
Julian E FuchsCenter of Molecular Biosciences & Institute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.
Hannes G WallnoeferCenter of Molecular Biosciences & Institute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.
Almedina IsakovicDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Vera KohlbauerDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Arthur HinterholzerDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Markus SteinerDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Martin DanzerAustrian Red Cross, Blood Transfusion Service for Upper Austria, Linz, Austria.
Jutta Horejs-HoeckDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Fatima FerreiraDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Klaus R LiedlCenter of Molecular Biosciences & Institute of General, Inorganic and Theoretical Chemistry, University of Innsbruck, Innsbruck, Austria.
Martin TollingerCenter of Molecular Biosciences & Institute of Organic Chemistry, University of Innsbruck, Innsbruck, Austria.
Peter LacknerDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Christopher M JohnsonMRC Laboratory of Molecular Biology, Cambridge, United Kingdom.
Hans BrandstetterDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Josef ThalhamerDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria.
Richard WeissDepartment of Molecular Biology, University of Salzburg, Salzburg, Austria. Electronic address: Richard.Weiss@sbg.ac.at.
University of Salzburg · ATUniversität Innsbruck · ATAustrian Red Cross · ATMRC Laboratory of Molecular Biology · GB

Funding

Austrian Science Fund FWF P 26849Austrian Science Fund FWF P 26997Austrian Science Fund FWF W 1213Medical Research Council MC_U105178788
6 · The paper itself

Abstract

backgroundThe search for intrinsic factors, which account for a protein's capability to act as an allergen, is ongoing. Fold stability has been identified as a molecular feature that affects processing and presentation, thereby influencing an antigen's immunologic properties.

objectiveWe assessed how changes in fold stability modulate the immunogenicity and sensitization capacity of the major birch pollen allergen Bet v 1.

methodsBy exploiting an exhaustive virtual mutation screening, we generated mutants of the prototype allergen Bet v 1 with enhanced thermal and chemical stability and rigidity. Structural changes were analyzed by means of x-ray crystallography, nuclear magnetic resonance, and molecular dynamics simulations. Stability was monitored by using differential scanning calorimetry, circular dichroism, and Fourier transform infrared spectroscopy. Endolysosomal degradation was simulated in vitro by using the microsomal fraction of JAWS II cells, followed by liquid chromatography coupled to mass spectrometry. Immunologic properties were characterized in vitro by using a human T-cell line specific for the immunodominant epitope of Bet v 1 and in vivo in an adjuvant-free BALB/c mouse model.

resultsFold stabilization of Bet v 1 was pH dependent and resulted in resistance to endosomal degradation at a pH of 5 or greater, affecting presentation of the immunodominant T-cell epitope in vitro. These properties translated in vivo into a strong allergy-promoting TH2-type immune response. Efficient TH2 cell activation required both an increased stability at the pH of the early endosome and efficient degradation at lower pH in the late endosomal/lysosomal compartment.

conclusionsOur data indicate that differential pH-dependent fold stability along endosomal maturation is an essential protein-inherent determinant of allergenicity.

Indexed as

AllergensAnimalsAntigens, PlantEndosomesFemaleHydrogen-Ion ConcentrationImmunoglobulin EImmunoglobulin GMice, Inbred BALB CMutationPollenProtein FoldingProtein StabilityAllergensAntigens, PlantBet v 1 allergen, BetulaImmunoglobulin EImmunoglobulin GAllergic sensitizationantigen processing and presentationBet v 1endolysosomal degradationmolecular allergologystructural stability

Identifiers

PMID26559323
PMCPMC4877439
OpenAlexW2214556914

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.